These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 377422)

  • 21. [Thrombocyte replacement with HL-A typed non-related single donors].
    Cornu P; Groff P; Weber W; Nissen C; Burri HP; Speck B
    Schweiz Med Wochenschr; 1976 Jun; 106(26):889-93. PubMed ID: 792998
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Platelet support in patients undergoing bone marrow transplantation.
    Bacigalupo A; Avanzi G; Van Lint MT; Reali G; Solda' A; Adami R; Strada P; Barbanti M; Podesta' M; Marmont A
    Haematologica; 1981 Feb; 66(1):80-90. PubMed ID: 6785170
    [No Abstract]   [Full Text] [Related]  

  • 23. France-transplant: kidney transplantation as a guide for bone-marrow grafting.
    Hors J; Busson M; Dausset J
    Transplant Proc; 1974 Dec; 6(4):421-8. PubMed ID: 4612893
    [No Abstract]   [Full Text] [Related]  

  • 24. Histocompatibility antigens immunogenetics and role of matching in clinical renal transplantation.
    Thorsby E
    Ann Clin Res; 1981; 13(4-5):199-214. PubMed ID: 7039480
    [No Abstract]   [Full Text] [Related]  

  • 25. [Kidney transplantation and blood transfusion--with special reference to preoperative blood transfusion].
    Taguchi Y; Okazaki H
    Masui; 1985 Oct; 34(10):1391-409. PubMed ID: 3912522
    [No Abstract]   [Full Text] [Related]  

  • 26. The human leucocyte antigen (HLA) system.
    Turner D
    Vox Sang; 2004 Jul; 87 Suppl1():87-90. PubMed ID: 15200613
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Platelet refractoriness due to combined anti-HLA and anti-HPA-5a alloantibodies: clinical management during myeloablative allogeneic HSCT and development of a quantitative MAIPA assay.
    Arber C; Bertrand G; Halter J; Boehlen F; Kaplan C; Gratwohl A
    Br J Haematol; 2007 Oct; 139(1):159-61. PubMed ID: 17854320
    [No Abstract]   [Full Text] [Related]  

  • 28. CD6+ T cell depleted allogeneic bone marrow transplantation from genotypically HLA nonidentical related donors.
    Soiffer RJ; Mauch P; Fairclough D; Alyea E; Anderson K; Fisher D; Freedman A; Bartlett-Pandite L; Robertson M; Schlossman R; Gollob J; Marcus K; Murray C; Kuhlman C; Freeman A; Nadler L; Ritz J
    Biol Blood Marrow Transplant; 1997 Apr; 3(1):11-7. PubMed ID: 9209736
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Blood transfusions, HLA-A and B, DR matching, graft survival, and clinical course after cadaveric kidney transplantation.
    van Es A; Persijn GG; van Hooff-Eijkenboom YE; Kalff MW; van Hooff JP
    Transplant Proc; 1981 Mar; 13(1 Pt 1):172-4. PubMed ID: 7022816
    [No Abstract]   [Full Text] [Related]  

  • 30. Successful engraftment in crossmatch-positive HLA-mismatched peripheral blood stem cell transplantation after depletion of antidonor cytotoxic HLA antibodies with rituximab and donor platelet infusion.
    Narimatsu H; Wake A; Miura Y; Tanaka H; Matsumura T; Takagi S; Kato D; Myojo T; Kusumi E; Masuoka K; Miyakoshi S; Morinaga S; Saji H; Ichinohe T; Taniguchi S
    Bone Marrow Transplant; 2005 Sep; 36(6):555-6. PubMed ID: 16007108
    [No Abstract]   [Full Text] [Related]  

  • 31. [Current immunologic aspects of kidney transplantation].
    Lenhard V; Dreikorn K; Opelz G
    Urologe A; 1982 Sep; 21(5):280-9. PubMed ID: 6758280
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Bleeding risk and platelet transfusion refractoriness in patients with acute myelogenous leukemia who undergo autologous stem cell transplantation.
    Toor AA; Choo SY; Little JA
    Bone Marrow Transplant; 2000 Aug; 26(3):315-20. PubMed ID: 10967572
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Prevention of HLA alloimmunization due to platelet transfusion].
    van Marwijk Kooy M; Brand A; Sintnicolaas K; van Prooijen HC
    Ned Tijdschr Geneeskd; 1988 Apr; 132(17):758-61. PubMed ID: 3374659
    [No Abstract]   [Full Text] [Related]  

  • 34. [Current status of human renal allograft and experimental prolongation of renal graft survival].
    Hirano T
    Hokkaido Igaku Zasshi; 1984 Jul; 59(4):389-92. PubMed ID: 6386637
    [No Abstract]   [Full Text] [Related]  

  • 35. HLA-A, -B, and -DR matching and preoperative transfusions in renal transplantation.
    Reinitz ER; Rhodes C; Ellis T; Goldman MH; Bacquero A; Mendez-Picon G; Lee HM; Carter WH; Mohanakumar T
    Transplant Proc; 1984 Dec; 16(6):1415-8. PubMed ID: 6390840
    [No Abstract]   [Full Text] [Related]  

  • 36. The HLA system in blood transfusion.
    Navarrete CV
    Baillieres Best Pract Res Clin Haematol; 2000 Dec; 13(4):511-32. PubMed ID: 11102274
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cadaveric graft survival, clinical course, blood transfusion, HLA (A and B) match, and DR match in adult patients transplanted in one centre.
    van Hooff JP; van Es A; Persijn GG; van Hooff-Eykenboom IJ; Kalff MW; van Rood JJ; de Graeff J
    Proc Eur Dial Transplant Assoc; 1979; 16():359-65. PubMed ID: 398507
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Thrombocyte replacement].
    Fröhlich C
    Hippokrates; 1978 Feb; 49(1):95-7. PubMed ID: 632119
    [No Abstract]   [Full Text] [Related]  

  • 39. Neutrophil antibodies: detection and clinical application.
    Clay ME; Kline WE
    Am J Med Technol; 1981 Oct; 47(10):805-11. PubMed ID: 7036743
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Alopecia areata after allogeneic bone marrow transplantation from an affected, human leukocyte antigen-matched sibling.
    Barahmani N; Whaley K; Duvic M
    J Am Acad Dermatol; 2003 Dec; 49(6):1192. PubMed ID: 14639420
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.